Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Rickels

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Psychotherapy and Psychosomatics|February 22, 2018
Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic ReviewGiada Benasi, Jenny Guidi, Emanuela Offidani, et al.
The Journal of Clinical Psychiatry|October 5, 2006
Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trialAlan D Feiger, Karl Rickels, Moira A Rynn, et al.
The Journal of Clinical Psychiatry|March 17, 2009
Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trialKarl Rickels, Maria Athanasiou, Donald S Robinson, et al.
Psychiatry Research|April 25, 2017
Genome-wide association study of treatment response to venlafaxine XR in generalized anxiety disorderJeesun Jung, Elisabeth A Tawa, Christine Muench, et al.
Diabetes|July 10, 2013
Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric diseaseKaren L Teff, Michael R Rickels, Joanna Grudziak, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Allopregnanolone levels and symptom improvement in severe premenstrual syndromeEllen W Freeman, Cheryl A Frye, Karl Rickels, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapyMoira Rynn, Felipe García-España, David J Greenblatt, et al.
International Clinical Psychopharmacology|August 16, 2008
A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorderAmir Garakani, Jose M Martinez, Sue Marcus, et al.
Psychotherapy and Psychosomatics|September 25, 2013
Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XRKarl Rickels, Bijan Etemad, Moira A Rynn, et al.
Journal of Women'S Health (2002)|December 7, 2010
Core symptoms that discriminate premenstrual syndromeEllen W Freeman, Steffanie M Halberstadt, Karl Rickels, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Psychotherapy and Psychosomatics|February 22, 2018
Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic ReviewGiada Benasi, Jenny Guidi, Emanuela Offidani, et al.
The Journal of Clinical Psychiatry|October 5, 2006
Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trialAlan D Feiger, Karl Rickels, Moira A Rynn, et al.
The Journal of Clinical Psychiatry|March 17, 2009
Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trialKarl Rickels, Maria Athanasiou, Donald S Robinson, et al.
Psychiatry Research|April 25, 2017
Genome-wide association study of treatment response to venlafaxine XR in generalized anxiety disorderJeesun Jung, Elisabeth A Tawa, Christine Muench, et al.
Diabetes|July 10, 2013
Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric diseaseKaren L Teff, Michael R Rickels, Joanna Grudziak, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Allopregnanolone levels and symptom improvement in severe premenstrual syndromeEllen W Freeman, Cheryl A Frye, Karl Rickels, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapyMoira Rynn, Felipe García-España, David J Greenblatt, et al.
International Clinical Psychopharmacology|August 16, 2008
A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorderAmir Garakani, Jose M Martinez, Sue Marcus, et al.
Psychotherapy and Psychosomatics|September 25, 2013
Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XRKarl Rickels, Bijan Etemad, Moira A Rynn, et al.
Journal of Women'S Health (2002)|December 7, 2010
Core symptoms that discriminate premenstrual syndromeEllen W Freeman, Steffanie M Halberstadt, Karl Rickels, et al.
Pageof 7